Letter: 5-Fluorocytosine treated chromomycosis.
D000284:Administration, Oral; D002862:Chromoblastomycosis / Q000188:drug therapy*; D003596:Cytosine / Q000031:analogs & derivatives*; D005437:Flucytosine / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D013827:Thiabendazole / Q000627:therapeutic use
D003596:Cytosine; D005437:Flucytosine; D013827:Thiabendazole